Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$9.8M
Filings
80
Firms Hired
4
Active Period
1999–2011
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1706
Preserve Access to Affordable Generics Act
2010 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Client expense: — · Firm income: $30,000
Matched citations: S. 369
Preserve Access to Affordable Generics Act
2010 · fourth_quarter · Firm: ACG ADVOCACY
Patent Reform Patent Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1706
Preserve Access to Affordable Generics Act
2010 · third_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs; and FY 2011 Financial Services and General Government Appropriations bill.
Client expense: — · Firm income: $30,000
Matched citations: S. 369
Preserve Access to Affordable Generics Act
2010 · third_quarter · Firm: ACG ADVOCACY
Patent Reform Patent Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Preserve Access to Affordable Generics Act
2010 · second_quarter · Firm: ACG ADVOCACY
Patent Reform Patent Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Preserve Access to Affordable Generics Act
2010 · second_quarter · Firm: CEPHALON, INC.
Patent Reform Patent Settlements S. 369 - Preserve Access to Affordable Generics Act
Client expense: $220,000 · Firm income: —
Matched citations: S. 369
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1706
Preserve Access to Affordable Generics Act
2010 · second_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs.
Client expense: — · Firm income: $30,000
Matched citations: S. 369
Preserve Access to Affordable Generics Act
2010 · second_quarter · Firm: ACG ADVOCACY
Patent Reform Patent Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Preserve Access to Affordable Generics Act
2010 · first_quarter · Firm: CEPHALON, INC.
Patent Reform Patent Settlements S. 369 - Preserve Access to Affordable Generics Act
Client expense: $280,000 · Firm income: —
Matched citations: S. 369
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues affecting the pharmaceutical industry in H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3590
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3590
Superfund Polluter Pays Act
2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Issues affecting the pharmaceutical industry in H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3962
Superfund Polluter Pays Act
2010 · first_quarter · Firm: WILLIAMS AND JENSEN, PLLC
Legislation concerning patent settlements between brand name and generic pharmaceutical companies including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3962
Preserve Access to Affordable Generics Act
2010 · first_quarter · Firm: ACG ADVOCACY
Patent Reform Patent Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Preserve Access to Affordable Generics Act
2009 · fourth_quarter · Firm: CEPHALON, INC.
Patent Reform Patent Settlements S. 369 - Preserve Access to Affordable Generics Act
Client expense: $250,000 · Firm income: —
Matched citations: S. 369
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act;
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3590
Superfund Polluter Pays Act
2009 · fourth_quarter · Firm: WILLIAMS AND JENSEN, PLLC
H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act;
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3962
Preserve Access to Affordable Generics Act
2009 · fourth_quarter · Firm: ACG ADVOCACY
Patent Reform Patient Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Preserve Access to Affordable Generics Act
2009 · third_quarter · Firm: ACG ADVOCACY
Patent Reform Patient Settlements S.369 - Preserve Access to Affordable Generics Act
Client expense: — · Firm income: $90,000
Matched citations: S.369
Provisions related to pharmaceutical patents S 515 & HR 1260
Client expense: $182,304 · Firm income: —
Matched citations: HR 1260
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: CEPHALON, INC.
Drug Importation S 525 & HR 1298 International Trade DEA Issues Pedigree
Client expense: $182,304 · Firm income: —
Matched citations: HR 1298
Protecting Consumer Access to Generic Drugs Act of 2009
2009 · first_quarter · Firm: CEPHALON, INC.
Medicare Issues FDA Issues Issues related to settlements with generics S 369 & HR 1706
Client expense: $182,304 · Firm income: —
Matched citations: HR 1706
Source: Senate LDA